SAMAALB Trademark

Trademark Overview


On Sunday, July 29, 2018, a trademark application was filed for SAMAALB with the United States Patent and Trademark Office. The USPTO has given the SAMAALB trademark a serial number of 79241267. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, October 2, 2023. This trademark is owned by Novartis AG. The SAMAALB trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pr...
samaalb

General Information


Serial Number79241267
Word MarkSAMAALB
Filing DateSunday, July 29, 2018
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, October 2, 2023
Registration Number5663867
Registration DateTuesday, January 29, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2018

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, October 2, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, October 23, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Monday, October 23, 2023DEATH OF INTERNATIONAL REGISTRATION
Friday, July 26, 2019NOTIFICATION PROCESSED BY IB
Wednesday, March 13, 2019FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 13, 2019FINAL DISPOSITION PROCESSED
Thursday, February 28, 2019GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, January 29, 2019REGISTERED-PRINCIPAL REGISTER
Friday, November 30, 2018NOTIFICATION PROCESSED BY IB
Tuesday, November 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, November 7, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 7, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 24, 2018NOTICE OF PUBLICATION
Tuesday, October 2, 2018APPLICATION FILING RECEIPT MAILED
Friday, September 28, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 28, 2018ASSIGNED TO EXAMINER
Wednesday, September 26, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 25, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, September 20, 2018SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB